Griffin Asset Management, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Griffin Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 05, 2019	SELL	$1.03 - $1.75 $721 - $1,225	-700 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$1.43 - $1.87 $1,001 - $1,309	700 New	700 $1,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.